Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (281-290 of 651) with videos related to

Pageof 66
Sort By:
Clinical and Experimental Rheumatology|June 24, 2020
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiationMatthias Schaier, Claudius Gottschalk, Florian Kälble, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
International Journal of Oncology|November 21, 2008
Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4Lara Tickenbrock, Sina Hehn, Bülent Sargin, et al.
BMC Cancer|November 22, 2023
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trialsJoseph Kauer, Emma P Freundt, Anita Schmitt, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Journal of Intensive Care|October 11, 2018
Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patientsRichard J Nies, Carsten Müller, Roman Pfister, et al.
Blood|September 8, 2009
E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative diseaseSrinivasa Rao Bandi, Christian Brandts, Marion Rensinghoff, et al.
Leukemia|August 5, 2025
Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutationsMarcus Bauer, Christoforos Vaxevanis, Nadja Jaekel, et al.
Bone Marrow Transplantation|January 31, 2021
Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complicationHao Dai, Olaf Penack, Aleksandar Radujkovic, et al.
Pageof 66

Showing results (281-290 of 651) with videos related to

Sort By:
Pageof 66
Clinical and Experimental Rheumatology|June 24, 2020
The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiationMatthias Schaier, Claudius Gottschalk, Florian Kälble, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Quality of Online Information on Multiple Myeloma Available for LaypersonsHenrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple MyelomaFelix Krummradt, Sandra Sauer, Petra Pavel, et al.
International Journal of Oncology|November 21, 2008
Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4Lara Tickenbrock, Sina Hehn, Bülent Sargin, et al.
BMC Cancer|November 22, 2023
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trialsJoseph Kauer, Emma P Freundt, Anita Schmitt, et al.
Frontiers in Immunology|April 25, 2022
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort StudyFelix Korell, Olaf Penack, Mike Mattie, et al.
Journal of Intensive Care|October 11, 2018
Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patientsRichard J Nies, Carsten Müller, Roman Pfister, et al.
Blood|September 8, 2009
E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative diseaseSrinivasa Rao Bandi, Christian Brandts, Marion Rensinghoff, et al.
Leukemia|August 5, 2025
Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutationsMarcus Bauer, Christoforos Vaxevanis, Nadja Jaekel, et al.
Bone Marrow Transplantation|January 31, 2021
Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complicationHao Dai, Olaf Penack, Aleksandar Radujkovic, et al.
Pageof 66